Fentanyl Transdermal Patch and Telotristat Ethyl: Interaction Details

Brand names
Telotristat Ethyl
Xermelo
Fentanyl Transdermal Patch
DuragesicAbstralSubsys +3 more
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Fentanyl Transdermal Patch and Telotristat Ethyl interaction:

Share

Share this interaction

Fentanyl Transdermal Patch

Brand names
  • Duragesic
  • Abstral
  • Subsys
  • Ionsys
  • Actiq
  • Fentora

What Happens When You Take Fentanyl Transdermal Patch With Telotristat Ethyl

What can happen when they are taken together (rated Major)

Reduced exposure of fentaNYL, reduced of fentaNYL and/or onset of withdrawal symptoms

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

When fentaNYL is taken together with a , plasma fentaNYL concentrations can fall. This may lessen the efficacy of fentaNYL, or it may trigger opioid withdrawal syndrome in a patient who has become physically dependent on fentaNYL.

Where cannot be avoided, the patient should be monitored for signs of opioid withdrawal, and an increase in the fentaNYL dosage may be considered until stable drug effects are reached. Once the CYP3A4 inducer is stopped, fentaNYL will rise.

That rise may heighten or extend both the therapeutic and the adverse effects of fentaNYL, including the risk of serious . If a CYP3A4 inducer is withdrawn, a lower fentaNYL dosage should be considered, and patients should be assessed frequently for signs of respiratory depression and .1432

The Fentanyl Transdermal Patch and Telotristat Ethyl Interaction, Explained

Xermelo (telotristat) is used for carcinoid syndrome diarrhea, and it can speed up the way your body breaks down certain medicines. Fentanyl patches (Duragesic) are broken down this same way. So with both, your body may clear fentanyl faster, and the patch may not control your pain as well. In someone who takes fentanyl regularly, it can also cause withdrawal symptoms like restlessness, sweating, achy muscles, or stomach upset.

Also, if Xermelo is stopped, fentanyl levels can climb back up, which may cause extra sleepiness or slowed breathing. Please keep using both as prescribed. Tell your pharmacist or doctor about any pain changes or withdrawal-like symptoms. Your care team can adjust your dose and monitor you closely.

Mechanism: Telotristat ethyl (a ) may induce CYP3A4-mediated of fentanyl, lowering fentanyl exposure (/). Fentanyl is active itself, not a , so reduces effect.

  • Effect: reduced analgesia and possible withdrawal in opioid-dependent patients.
  • Evidence: probable; onset unspecified; severity major.
  • Management: if is needed, monitor for withdrawal and consider titrating fentanyl until stable effect.
  • On inducer discontinuation: fentanyl levels rise, with risk of prolonged effects and serious . Consider dose reduction and frequent evaluation for and respiratory depression.

See the 6 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Fentanyl Transdermal Patch and Telotristat Ethyl Interact

The likely mechanism

of -mediated of fentaNYL

In short: Telotristat ethyl speeds up CYP3A4, an enzyme that breaks down fentanyl, so fentanyl can be cleared faster.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Lowers Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Fentanyl Transdermal Patch and Telotristat Ethyl Interaction

Your care team can manage this by tailoring your fentanyl dose and monitoring you more closely.

  • Keep using both medicines as prescribed. Do not change or stop either one on your own.
  • Your team may watch for withdrawal signs or poorly controlled pain, and may increase your fentanyl dose until your response is stable.
  • If Xermelo is ever stopped, your fentanyl dose may need to be lowered, and you may be checked often for sleepiness or slow breathing.
  • Tell your pharmacist or prescriber about any new pain, withdrawal-like symptoms, or unusual drowsiness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Fentanyl Transdermal Patch or Telotristat Ethyl need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1

    A 64-year-old man taking rifAMPin, a strong ,5 could not obtain adequate pain control with optimized doses of transdermal fentaNYL and rescue pain medications until he was changed to morphine. The patient, who had colon cancer, was taking rifAMPin 450 mg/day as part of an antitubercular regimen for pulmonary tuberculosis.

    Pain control was not achieved even though the fentaNYL dose was increased from 0.6 mg/day to 2.5 mg/day and rescue medication was given. When fentaNYL was replaced with sustained-release oral morphine at a dose analgesically equivalent to fentaNYL (180 mg/day), pain control was achieved.

    Afterward, however, the patient developed a disturbance in consciousness, which was attributed to a morphine side effect. According to the Naranjo probability scale, rifAMPin was a possible cause of the lack of response to fentaNYL.6

Fentanyl Transdermal Patch and Telotristat Ethyl: Common Questions

How serious is the Fentanyl Transdermal Patch and Telotristat Ethyl interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Fentanyl Transdermal Patch and Telotristat Ethyl interaction managed?

Your care team can manage this by tailoring your fentanyl dose and monitoring you more closely. Keep using both medicines as prescribed. Do not change or stop either one on your own. Your team may watch for withdrawal signs or poorly controlled pain, and may increase your fentanyl dose until your response is stable. If Xermelo is ever stopped, your fentanyl dose may need to be lowered, and you may… Management is individual — always follow your own care team's guidance.

Does taking Fentanyl Transdermal Patch and Telotristat Ethyl at different times of day help?

No. Taking them at different times of day does not prevent this one. Telotristat ethyl speeds up , an enzyme that breaks down fentanyl, so fentanyl can be cleared faster. That change lasts while telotristat ethyl is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Fentanyl Transdermal Patch and Telotristat Ethyl Interaction

Ask in your own words about taking Fentanyl Transdermal Patch and Telotristat Ethyl together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (6)

  1. Product Information: DURAGESIC(R) transdermal system, fentanyl transdermal system. Janssen Pharmaceuticals Inc (per manufacturer), Titusville, NJ, 2018. DailyMed
  2. Product Information: ACTIQ(R) oral transmucosal lozenge, fentanyl citrate oral transmucosal lozenge. Teva Pharmaceuticals USA, Inc. (per FDA), Parsippany, NJ, 2023. DailyMed
  3. Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Hospira Inc (per FDA), Lake Forest, IL, 2023. DailyMed
  4. Product Information: FENTORA(R) buccal tablets, fentanyl citrate buccal tablets. Teva Pharmaceuticals USA Inc (per FDA), Parsippany, NJ, 2023.
  5. Certara Drug Interactions Solutions: Certara Drug Interaction Database (DIDB(R)). Princeton, NJ: Certara, May 2024.
  6. Morii H, Chiba M, Konishi H, et al: Failure of pain control using transdermal fentanyl during rifampicin treatment. J Pain Symptom Manage 2007; 33(1):5-6. PubMed
Was this write-up helpful?

Other Serious Interactions of Fentanyl Transdermal Patch and Telotristat Ethyl

Also serious with Telotristat Ethyl

Also serious with Fentanyl Transdermal Patch

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.